Berry GenomicsLtd Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Berry GenomicsLtd has a total shareholder equity of CN¥1.9B and total debt of CN¥107.0M, which brings its debt-to-equity ratio to 5.6%. Its total assets and total liabilities are CN¥2.5B and CN¥631.3M respectively.
Anahtar bilgiler
5.6%
Borç/özkaynak oranı
CN¥107.00m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | CN¥241.93m |
| Eşitlik | CN¥1.91b |
| Toplam yükümlülükler | CN¥631.32m |
| Toplam varlıklar | CN¥2.54b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 000710's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥591.8M).
Uzun Vadeli Yükümlülükler: 000710's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥39.6M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 000710 has more cash than its total debt.
Borcun Azaltılması: 000710's debt to equity ratio has reduced from 8% to 5.6% over the past 5 years.
Borç Kapsamı: 000710's debt is well covered by operating cash flow (119.1%).
Faiz Kapsamı: Insufficient data to determine if 000710's interest payments on its debt are well covered by EBIT.